Hassane Zarour

Hassane Zarour investigates the interplay between gut microbiome and anti-tumor immunity with focus on how microbiome composition shapes T cell differentiation and anti-PD-1 response in melanoma patients. His laboratory has characterized specific bacterial species associated with CD8 T cell expansion and immunotherapy benefit. He has led translational studies integrating microbiome profiling with immune monitoring in melanoma patients undergoing checkpoint blockade. His work aims to develop microbiome-based biomarkers and interventions to optimize immunotherapy outcomes.